Our Experience

ICRC-Wey­er has a sophis­ti­cat­ed team of experts with both young and moti­vat­ed employ­ees and long-term mem­bers with immense expe­ri­ence in our field of busi­ness. This mix­ture paired with qual­i­ty focus and con­tin­u­ous team train­ing is reflect­ed in a large num­ber of suc­cess­ful­ly final­ized projects. We pro­vide con­sult­ing on spe­cif­ic sci­en­tif­ic ques­tions and cov­er either indi­vid­ual func­tion­al ser­vice for clin­i­cal tri­als or full ser­vice and res­cue sup­port of clin­i­cal tri­als and beyond for our clients.

ICRC-Wey­er sup­ports clin­i­cal tri­als of phase I‑IV, from First-in-Human up to glob­al phase III tri­als. We are also active in non-inter­ven­tion­al and post-mar­ket­ing stud­ies, inves­ti­ga­tor-ini­ti­at­ed tri­als of all types and non-tri­al relat­ed projects. Based on this expe­ri­ence we can cov­er client needs in EDC data col­lec­tion, data man­age­ment and bio­sta­tis­tics for every study, be it an ear­ly phase or proof of con­cept tri­al for a small start-up biotech com­pa­ny or sub­mis­sion sup­port for big phar­ma companies.

ICRC-Wey­er is expe­ri­enced in a wide range of dif­fer­ent indi­ca­tions with extend­ed exper­tise in areas like Oncol­o­gy, Haema­tol­ogy, Immunol­o­gy, Car­dio­vas­cu­lar dis­eases, Neu­rode­gen­er­a­tion and Neu­roin­flam­ma­to­ry dis­eases. Please feel free to ask for sup­port for your spe­cif­ic indication.

ICRC-Wey­er has con­sid­er­able expe­ri­ence in the spe­cial­ized area of safe­ty writ­ing con­cern­ing the full range of dif­fer­ent phar­ma­covig­i­lance doc­u­ments, e.g. RMPs, PSURs/PBRERs and DSURs. Clients val­ue this spe­cial aspect of our work in close inter­ac­tion with our experts.

For Med­ical Review, ICRC-Wey­er devel­oped a sys­tem of met­rics cen­tered on the num­ber and ratio of med­ical queries which can be pos­i­tive­ly resolved.